Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iodide Peroxidase | 77 | 2011 | 293 | 8.350 |
Why?
|
Triiodothyronine | 44 | 2008 | 491 | 2.680 |
Why?
|
Thyroid Hormones | 20 | 2008 | 387 | 1.470 |
Why?
|
Thyroxine | 30 | 2006 | 666 | 1.430 |
Why?
|
Selenocysteine | 14 | 2000 | 124 | 1.160 |
Why?
|
Receptors, Thyroid Hormone | 17 | 2004 | 202 | 1.120 |
Why?
|
Thyroid Gland | 17 | 2005 | 1169 | 1.030 |
Why?
|
Hypothyroidism | 16 | 2006 | 659 | 0.820 |
Why?
|
RNA, Messenger | 29 | 2009 | 13002 | 0.600 |
Why?
|
Promoter Regions, Genetic | 23 | 2005 | 5863 | 0.580 |
Why?
|
Isoenzymes | 10 | 2004 | 1720 | 0.570 |
Why?
|
Thyrotoxicosis | 4 | 2004 | 82 | 0.530 |
Why?
|
Molecular Sequence Data | 43 | 2008 | 18125 | 0.510 |
Why?
|
Cysteine | 9 | 2000 | 870 | 0.510 |
Why?
|
Rats | 54 | 2010 | 24270 | 0.500 |
Why?
|
Selenium | 8 | 2001 | 402 | 0.480 |
Why?
|
Growth Hormone | 10 | 2001 | 703 | 0.440 |
Why?
|
Base Sequence | 33 | 2002 | 12804 | 0.430 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2005 | 862 | 0.390 |
Why?
|
Eating | 4 | 2010 | 1526 | 0.380 |
Why?
|
Cyclic AMP | 7 | 2004 | 1470 | 0.370 |
Why?
|
Pituitary Gland | 6 | 2009 | 667 | 0.350 |
Why?
|
Adipose Tissue, Brown | 6 | 2001 | 754 | 0.340 |
Why?
|
Obesity | 10 | 2011 | 12643 | 0.330 |
Why?
|
Cysteine Endopeptidases | 3 | 2000 | 561 | 0.330 |
Why?
|
Propylthiouracil | 9 | 2002 | 69 | 0.310 |
Why?
|
Iodine Radioisotopes | 5 | 2005 | 1031 | 0.310 |
Why?
|
Codon | 4 | 1993 | 613 | 0.310 |
Why?
|
Genomic Imprinting | 1 | 2009 | 331 | 0.310 |
Why?
|
Multienzyme Complexes | 3 | 2000 | 687 | 0.300 |
Why?
|
Amino Acid Sequence | 23 | 2008 | 13816 | 0.300 |
Why?
|
Iodine | 4 | 2001 | 285 | 0.300 |
Why?
|
Gene Expression | 14 | 2003 | 7788 | 0.300 |
Why?
|
Thyrotropin | 14 | 2009 | 849 | 0.300 |
Why?
|
Transfection | 23 | 2008 | 5884 | 0.290 |
Why?
|
Hyperthyroidism | 4 | 1999 | 293 | 0.280 |
Why?
|
Kinetics | 15 | 2004 | 6475 | 0.280 |
Why?
|
Peptide YY | 1 | 2006 | 130 | 0.270 |
Why?
|
Animals | 86 | 2011 | 168368 | 0.270 |
Why?
|
Protein Biosynthesis | 6 | 2002 | 2131 | 0.270 |
Why?
|
Transcription Factors | 8 | 2005 | 12120 | 0.270 |
Why?
|
Cloning, Molecular | 11 | 2003 | 4319 | 0.260 |
Why?
|
Down-Regulation | 2 | 2004 | 2999 | 0.250 |
Why?
|
Muscle Proteins | 2 | 2001 | 1158 | 0.250 |
Why?
|
Receptors, Adrenergic | 1 | 2004 | 155 | 0.240 |
Why?
|
Arteriosclerosis | 2 | 2005 | 1092 | 0.230 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2004 | 246 | 0.230 |
Why?
|
DNA, Complementary | 8 | 1999 | 2049 | 0.230 |
Why?
|
Adipose Tissue | 6 | 2011 | 3280 | 0.220 |
Why?
|
Response Elements | 1 | 2004 | 310 | 0.220 |
Why?
|
Placenta | 4 | 2003 | 1682 | 0.220 |
Why?
|
Insulin Resistance | 6 | 2011 | 3858 | 0.210 |
Why?
|
Pituitary Neoplasms | 5 | 1998 | 1334 | 0.210 |
Why?
|
Leptin | 2 | 2010 | 1589 | 0.210 |
Why?
|
5' Untranslated Regions | 2 | 2002 | 250 | 0.210 |
Why?
|
Methimazole | 4 | 2002 | 41 | 0.210 |
Why?
|
Pregnancy Complications | 5 | 2004 | 2867 | 0.200 |
Why?
|
Adrenergic alpha-Agonists | 3 | 1991 | 177 | 0.200 |
Why?
|
Thyroid Nodule | 6 | 2007 | 750 | 0.200 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2002 | 1213 | 0.200 |
Why?
|
Liver | 12 | 2011 | 7449 | 0.200 |
Why?
|
Cell Line | 20 | 2005 | 15987 | 0.190 |
Why?
|
Heart | 3 | 2004 | 4466 | 0.190 |
Why?
|
Vascular Neoplasms | 1 | 2002 | 174 | 0.190 |
Why?
|
Catalysis | 6 | 2008 | 759 | 0.190 |
Why?
|
Proteins | 6 | 2005 | 6082 | 0.190 |
Why?
|
Myocardium | 4 | 2004 | 4788 | 0.190 |
Why?
|
Ion Channels | 3 | 2001 | 1056 | 0.190 |
Why?
|
Consensus Sequence | 5 | 1999 | 378 | 0.180 |
Why?
|
Transcription, Genetic | 9 | 2005 | 7709 | 0.180 |
Why?
|
Graves Disease | 1 | 2002 | 241 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 11 | 2010 | 8299 | 0.180 |
Why?
|
Thiazolidinediones | 1 | 2003 | 474 | 0.180 |
Why?
|
Blotting, Northern | 6 | 1999 | 1583 | 0.180 |
Why?
|
Endocrinology | 2 | 1997 | 440 | 0.180 |
Why?
|
Hemangioma | 2 | 2005 | 738 | 0.170 |
Why?
|
Organoselenium Compounds | 2 | 1996 | 23 | 0.170 |
Why?
|
Triiodothyronine, Reverse | 5 | 2000 | 23 | 0.170 |
Why?
|
Hormones | 3 | 2003 | 880 | 0.170 |
Why?
|
Antithyroid Agents | 2 | 2002 | 68 | 0.170 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2002 | 435 | 0.170 |
Why?
|
Repetitive Sequences, Nucleic Acid | 6 | 1998 | 794 | 0.170 |
Why?
|
Energy Metabolism | 3 | 2009 | 2896 | 0.170 |
Why?
|
Membrane Proteins | 4 | 2009 | 7862 | 0.170 |
Why?
|
Uterus | 1 | 2003 | 712 | 0.160 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1998 | 94 | 0.160 |
Why?
|
Acclimatization | 1 | 1998 | 103 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 7 | 2008 | 2833 | 0.160 |
Why?
|
Binding Sites | 11 | 2003 | 6113 | 0.160 |
Why?
|
Aurothioglucose | 2 | 1995 | 11 | 0.160 |
Why?
|
Genes | 4 | 1996 | 1898 | 0.150 |
Why?
|
Estradiol | 4 | 2005 | 2021 | 0.150 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1997 | 0.150 |
Why?
|
Body Temperature Regulation | 1 | 1998 | 252 | 0.150 |
Why?
|
Nucleic Acid Conformation | 5 | 2002 | 913 | 0.150 |
Why?
|
Up-Regulation | 2 | 2009 | 4205 | 0.150 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4463 | 0.150 |
Why?
|
DNA Transposable Elements | 2 | 2002 | 749 | 0.150 |
Why?
|
Alternative Splicing | 1 | 2002 | 1117 | 0.140 |
Why?
|
Body Weight | 3 | 2009 | 4660 | 0.140 |
Why?
|
Cycloheximide | 5 | 2003 | 347 | 0.140 |
Why?
|
Rats, Inbred Strains | 7 | 1991 | 2198 | 0.140 |
Why?
|
DNA | 12 | 2001 | 7275 | 0.140 |
Why?
|
Endopeptidases | 1 | 2000 | 771 | 0.140 |
Why?
|
Thyroid Diseases | 4 | 1994 | 378 | 0.140 |
Why?
|
Thyroid Function Tests | 3 | 1995 | 284 | 0.140 |
Why?
|
Conserved Sequence | 4 | 2005 | 1203 | 0.140 |
Why?
|
Insulin | 4 | 2010 | 6569 | 0.130 |
Why?
|
Rats, Wistar | 3 | 2009 | 1894 | 0.130 |
Why?
|
Gold Sodium Thiomalate | 1 | 1995 | 10 | 0.130 |
Why?
|
Blood Glucose | 7 | 2010 | 6237 | 0.130 |
Why?
|
Fetus | 1 | 2003 | 1877 | 0.130 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 1995 | 57 | 0.130 |
Why?
|
Affinity Labels | 2 | 1992 | 109 | 0.130 |
Why?
|
Cold Temperature | 1 | 1998 | 775 | 0.130 |
Why?
|
Structure-Activity Relationship | 8 | 2003 | 3146 | 0.130 |
Why?
|
Dimerization | 3 | 2008 | 892 | 0.120 |
Why?
|
Hypothalamus | 3 | 2009 | 1066 | 0.120 |
Why?
|
Chickens | 4 | 2002 | 864 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2001 | 1310 | 0.120 |
Why?
|
Mutagenesis | 4 | 2000 | 1265 | 0.120 |
Why?
|
Models, Chemical | 3 | 2005 | 628 | 0.120 |
Why?
|
Tumor Cells, Cultured | 8 | 2001 | 6310 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 7 | 2003 | 1721 | 0.120 |
Why?
|
Luciferases | 1 | 1996 | 734 | 0.120 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 1 | 1993 | 24 | 0.120 |
Why?
|
Pituitary Gland, Anterior | 3 | 2003 | 177 | 0.120 |
Why?
|
Central Nervous System | 1 | 2001 | 1362 | 0.120 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 2000 | 222 | 0.120 |
Why?
|
Skin Abnormalities | 1 | 1994 | 60 | 0.110 |
Why?
|
Thyroid Neoplasms | 6 | 2006 | 2267 | 0.110 |
Why?
|
Plasmids | 6 | 2000 | 2307 | 0.110 |
Why?
|
DNA Primers | 4 | 2000 | 2893 | 0.110 |
Why?
|
In Situ Hybridization | 5 | 2006 | 1934 | 0.110 |
Why?
|
Gene Expression Regulation | 7 | 2006 | 12049 | 0.110 |
Why?
|
Nuclear Proteins | 4 | 2004 | 5830 | 0.110 |
Why?
|
Organ Size | 3 | 2003 | 2247 | 0.110 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 782 | 0.110 |
Why?
|
Humans | 76 | 2009 | 739398 | 0.110 |
Why?
|
Cells, Cultured | 11 | 2008 | 19220 | 0.110 |
Why?
|
Genes, Reporter | 1 | 1996 | 1549 | 0.110 |
Why?
|
Awards and Prizes | 1 | 1997 | 375 | 0.100 |
Why?
|
Half-Life | 3 | 2002 | 658 | 0.100 |
Why?
|
Selenoproteins | 4 | 2002 | 216 | 0.100 |
Why?
|
Glucose Tolerance Test | 4 | 2011 | 1149 | 0.100 |
Why?
|
Mutation | 14 | 2004 | 29658 | 0.100 |
Why?
|
Dexamethasone | 4 | 2001 | 1948 | 0.100 |
Why?
|
Diet | 5 | 2011 | 7876 | 0.100 |
Why?
|
Codon, Initiator | 2 | 2002 | 52 | 0.100 |
Why?
|
Protein Synthesis Inhibitors | 3 | 2001 | 192 | 0.100 |
Why?
|
Selenium Radioisotopes | 3 | 2003 | 13 | 0.100 |
Why?
|
Sequence Alignment | 4 | 1997 | 2256 | 0.100 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 3 | 1998 | 76 | 0.100 |
Why?
|
Kidney Tubules, Proximal | 1 | 1993 | 415 | 0.100 |
Why?
|
Polymorphism, Genetic | 3 | 2008 | 4332 | 0.100 |
Why?
|
Thyrotropin-Releasing Hormone | 3 | 1998 | 147 | 0.100 |
Why?
|
Endoplasmic Reticulum | 4 | 2005 | 1141 | 0.100 |
Why?
|
Mice | 17 | 2011 | 81002 | 0.090 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1837 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2001 | 9622 | 0.090 |
Why?
|
Biopsy, Needle | 3 | 2005 | 1637 | 0.090 |
Why?
|
PC12 Cells | 1 | 2009 | 330 | 0.090 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2003 | 320 | 0.090 |
Why?
|
Calcium-Transporting ATPases | 2 | 2001 | 123 | 0.080 |
Why?
|
Male | 39 | 2011 | 349022 | 0.080 |
Why?
|
Mice, Inbred C57BL | 8 | 2011 | 21863 | 0.080 |
Why?
|
Homeostasis | 4 | 2009 | 3348 | 0.080 |
Why?
|
Mice, Obese | 1 | 2009 | 425 | 0.080 |
Why?
|
3' Untranslated Regions | 2 | 2002 | 508 | 0.080 |
Why?
|
Tretinoin | 3 | 1998 | 513 | 0.080 |
Why?
|
Amino Acids | 1 | 1994 | 1727 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 1 | 1989 | 346 | 0.080 |
Why?
|
Recombinant Proteins | 7 | 2003 | 6610 | 0.080 |
Why?
|
Alanine | 2 | 2000 | 578 | 0.080 |
Why?
|
Ubiquitins | 2 | 2000 | 382 | 0.080 |
Why?
|
Mice, Inbred C3H | 3 | 2006 | 971 | 0.080 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 1998 | 102 | 0.080 |
Why?
|
Hormone Antagonists | 1 | 2007 | 107 | 0.070 |
Why?
|
Pancreas | 2 | 2009 | 1678 | 0.070 |
Why?
|
Potassium Channels | 2 | 2001 | 563 | 0.070 |
Why?
|
Protein Conformation | 1 | 1995 | 4012 | 0.070 |
Why?
|
Bile Acids and Salts | 1 | 2009 | 354 | 0.070 |
Why?
|
Gene Library | 2 | 2001 | 1077 | 0.070 |
Why?
|
Dogs | 4 | 1997 | 3915 | 0.070 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1988 | 821 | 0.070 |
Why?
|
Thioredoxins | 2 | 2005 | 213 | 0.070 |
Why?
|
Microsomes | 3 | 1996 | 257 | 0.070 |
Why?
|
Sp1 Transcription Factor | 2 | 1998 | 144 | 0.070 |
Why?
|
Tamoxifen | 1 | 1991 | 978 | 0.070 |
Why?
|
Disulfides | 2 | 2005 | 458 | 0.070 |
Why?
|
Genomic Library | 3 | 1996 | 192 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 1998 | 3694 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2006 | 154 | 0.070 |
Why?
|
Kidney | 9 | 2004 | 7144 | 0.070 |
Why?
|
Norepinephrine | 2 | 2004 | 910 | 0.070 |
Why?
|
Osmolar Concentration | 2 | 1997 | 683 | 0.070 |
Why?
|
Iduronidase | 1 | 2005 | 31 | 0.070 |
Why?
|
Biopsy, Fine-Needle | 2 | 2007 | 1089 | 0.070 |
Why?
|
Drug Monitoring | 1 | 1992 | 961 | 0.070 |
Why?
|
Maternal-Fetal Exchange | 2 | 2001 | 454 | 0.070 |
Why?
|
Dithiothreitol | 3 | 2003 | 101 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2007 | 9734 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 1991 | 1871 | 0.060 |
Why?
|
Xenobiotics | 1 | 2005 | 69 | 0.060 |
Why?
|
Cell Membrane | 3 | 2004 | 3747 | 0.060 |
Why?
|
Taste | 1 | 2006 | 175 | 0.060 |
Why?
|
Introns | 2 | 2000 | 992 | 0.060 |
Why?
|
Smad Proteins | 1 | 2005 | 162 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2000 | 1331 | 0.060 |
Why?
|
DNA Footprinting | 1 | 2004 | 98 | 0.060 |
Why?
|
Rodentia | 1 | 2006 | 260 | 0.060 |
Why?
|
Protein Folding | 2 | 2005 | 842 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4216 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 196 | 0.060 |
Why?
|
Phenytoin | 1 | 2005 | 198 | 0.060 |
Why?
|
Phenobarbital | 1 | 2005 | 190 | 0.060 |
Why?
|
Receptors, Steroid | 1 | 2005 | 155 | 0.060 |
Why?
|
Hypothalamus, Middle | 1 | 2003 | 25 | 0.060 |
Why?
|
Organ Specificity | 4 | 1997 | 2004 | 0.060 |
Why?
|
Prediabetic State | 1 | 2009 | 484 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 628 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 301 | 0.060 |
Why?
|
Rats, Mutant Strains | 1 | 2003 | 70 | 0.060 |
Why?
|
Phenylpropionates | 1 | 2003 | 30 | 0.060 |
Why?
|
Xenopus | 2 | 1998 | 711 | 0.060 |
Why?
|
Adiponectin | 2 | 2009 | 1096 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1995 | 769 | 0.060 |
Why?
|
Muscle, Skeletal | 3 | 2005 | 4920 | 0.060 |
Why?
|
Keratinocytes | 1 | 2007 | 793 | 0.060 |
Why?
|
Fenofibrate | 1 | 2003 | 89 | 0.060 |
Why?
|
Triglycerides | 2 | 2009 | 2447 | 0.060 |
Why?
|
Protein Kinase C | 1 | 1988 | 1223 | 0.060 |
Why?
|
Histocytochemistry | 2 | 2006 | 723 | 0.060 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 548 | 0.050 |
Why?
|
Societies, Medical | 1 | 1995 | 3739 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2003 | 193 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2007 | 774 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2005 | 645 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 475 | 0.050 |
Why?
|
Aortic Diseases | 2 | 2005 | 734 | 0.050 |
Why?
|
Absorptiometry, Photon | 2 | 2005 | 1726 | 0.050 |
Why?
|
Ultrasonography | 5 | 2007 | 5941 | 0.050 |
Why?
|
Oxazines | 1 | 2003 | 302 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 889 | 0.050 |
Why?
|
Umbilical Cord | 1 | 2003 | 179 | 0.050 |
Why?
|
Trans-Activators | 3 | 2007 | 2922 | 0.050 |
Why?
|
Macromolecular Substances | 2 | 1996 | 1457 | 0.050 |
Why?
|
Glutathione Peroxidase | 2 | 1993 | 256 | 0.050 |
Why?
|
Pregnancy | 7 | 2004 | 29002 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2010 | 18003 | 0.050 |
Why?
|
Models, Molecular | 3 | 2008 | 5460 | 0.050 |
Why?
|
Female | 25 | 2009 | 378853 | 0.050 |
Why?
|
Chick Embryo | 2 | 2001 | 978 | 0.050 |
Why?
|
Adenine Nucleotides | 1 | 2001 | 121 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4743 | 0.050 |
Why?
|
Molecular Structure | 1 | 2005 | 1925 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2006 | 11347 | 0.050 |
Why?
|
Anthropometry | 1 | 2005 | 1344 | 0.050 |
Why?
|
Sequence Homology | 1 | 2001 | 203 | 0.050 |
Why?
|
Weight Loss | 2 | 2010 | 2589 | 0.050 |
Why?
|
Exopeptidases | 1 | 2000 | 2 | 0.050 |
Why?
|
Epithelium | 1 | 2005 | 1684 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 643 | 0.050 |
Why?
|
Ependyma | 1 | 2000 | 56 | 0.050 |
Why?
|
Gastric Bypass | 1 | 2009 | 809 | 0.050 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 127 | 0.050 |
Why?
|
Retreatment | 1 | 2002 | 603 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2002 | 877 | 0.050 |
Why?
|
Ubiquitin | 1 | 2005 | 847 | 0.050 |
Why?
|
Endometrium | 1 | 2003 | 425 | 0.050 |
Why?
|
Pyrroles | 1 | 2006 | 1142 | 0.050 |
Why?
|
Cyclobutanes | 2 | 2010 | 59 | 0.050 |
Why?
|
TATA Box | 1 | 2000 | 128 | 0.050 |
Why?
|
Paired Box Transcription Factors | 1 | 2001 | 215 | 0.050 |
Why?
|
DNA Mutational Analysis | 3 | 1994 | 4182 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2001 | 273 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1991 | 1158 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4935 | 0.040 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 1999 | 19 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2000 | 547 | 0.040 |
Why?
|
Endosomes | 1 | 2002 | 527 | 0.040 |
Why?
|
Dactinomycin | 2 | 2001 | 317 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2004 | 972 | 0.040 |
Why?
|
Glutathione | 2 | 2002 | 585 | 0.040 |
Why?
|
Brain | 5 | 2001 | 26345 | 0.040 |
Why?
|
Ranidae | 1 | 1999 | 33 | 0.040 |
Why?
|
GMP Reductase | 1 | 1998 | 3 | 0.040 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1998 | 24 | 0.040 |
Why?
|
Receptors, Retinoic Acid | 3 | 1995 | 232 | 0.040 |
Why?
|
Cytochalasin B | 1 | 1998 | 74 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 2000 | 460 | 0.040 |
Why?
|
Uncoupling Agents | 1 | 1998 | 45 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2000 | 2503 | 0.040 |
Why?
|
Xenopus laevis | 2 | 1995 | 953 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 416 | 0.040 |
Why?
|
Ischemia | 1 | 2008 | 1908 | 0.040 |
Why?
|
Leupeptins | 1 | 1998 | 122 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2003 | 606 | 0.040 |
Why?
|
Body Composition | 2 | 2005 | 2397 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2001 | 694 | 0.040 |
Why?
|
Ligands | 2 | 1996 | 3311 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 489 | 0.040 |
Why?
|
Indoles | 1 | 2006 | 1832 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1675 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 1996 | 1783 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2001 | 1967 | 0.040 |
Why?
|
Chromosome Mapping | 3 | 1996 | 4743 | 0.040 |
Why?
|
Feeding Behavior | 2 | 2010 | 3180 | 0.040 |
Why?
|
Cysts | 1 | 2003 | 674 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2000 | 515 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2010 | 331 | 0.040 |
Why?
|
Iopanoic Acid | 2 | 1991 | 20 | 0.040 |
Why?
|
Chloroquine | 1 | 1998 | 280 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2455 | 0.040 |
Why?
|
Molecular Weight | 3 | 2003 | 2257 | 0.040 |
Why?
|
Transcription Factor Pit-1 | 1 | 1996 | 16 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9387 | 0.040 |
Why?
|
Lipids | 2 | 2010 | 3307 | 0.040 |
Why?
|
Models, Biological | 4 | 2005 | 9609 | 0.040 |
Why?
|
Sulfuric Acid Esters | 1 | 1996 | 33 | 0.040 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1996 | 158 | 0.040 |
Why?
|
Carrier Proteins | 3 | 1998 | 5012 | 0.040 |
Why?
|
Postmenopause | 1 | 2005 | 2456 | 0.040 |
Why?
|
Drug Synergism | 2 | 1991 | 1792 | 0.040 |
Why?
|
Electrophysiology | 1 | 1999 | 1309 | 0.040 |
Why?
|
Species Specificity | 1 | 2001 | 2480 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 599 | 0.030 |
Why?
|
Isomerism | 1 | 1996 | 201 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1488 | 0.030 |
Why?
|
Substrate Specificity | 2 | 1997 | 1798 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 425 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2208 | 0.030 |
Why?
|
Retinoid X Receptors | 1 | 1995 | 92 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2719 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1996 | 228 | 0.030 |
Why?
|
Gene Rearrangement | 2 | 2003 | 1178 | 0.030 |
Why?
|
Enzyme Induction | 2 | 2008 | 475 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2004 | 1625 | 0.030 |
Why?
|
Mesothelioma | 1 | 2001 | 817 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12951 | 0.030 |
Why?
|
Cell-Free System | 1 | 1995 | 346 | 0.030 |
Why?
|
Adult | 12 | 2009 | 213394 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1995 | 879 | 0.030 |
Why?
|
Fibroblasts | 1 | 2005 | 4137 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1998 | 792 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2361 | 0.030 |
Why?
|
Hypoglycemic Agents | 2 | 2003 | 2861 | 0.030 |
Why?
|
Body Mass Index | 3 | 2009 | 12655 | 0.030 |
Why?
|
Malate Dehydrogenase | 1 | 1993 | 41 | 0.030 |
Why?
|
Selenoprotein P | 1 | 1993 | 32 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 1993 | 176 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 112 | 0.030 |
Why?
|
Muramidase | 1 | 1993 | 174 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5076 | 0.030 |
Why?
|
Teratogens | 1 | 1994 | 113 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2278 | 0.030 |
Why?
|
Kidney Cortex | 1 | 1993 | 186 | 0.030 |
Why?
|
Kidney Medulla | 1 | 1993 | 182 | 0.030 |
Why?
|
Histidine | 1 | 1993 | 313 | 0.030 |
Why?
|
Molecular Biology | 1 | 1996 | 594 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 1998 | 989 | 0.030 |
Why?
|
Eukaryotic Cells | 1 | 1993 | 198 | 0.030 |
Why?
|
Congenital Hypothyroidism | 1 | 1992 | 39 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 1998 | 2022 | 0.030 |
Why?
|
Arthritis, Psoriatic | 1 | 1995 | 212 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 3 | 1989 | 4555 | 0.030 |
Why?
|
Diazonium Compounds | 1 | 1991 | 18 | 0.030 |
Why?
|
Phenotype | 2 | 2009 | 16301 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1883 | 0.030 |
Why?
|
Proline | 1 | 1993 | 454 | 0.030 |
Why?
|
Actins | 1 | 1999 | 2112 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2004 | 3799 | 0.030 |
Why?
|
Mammals | 1 | 1997 | 1112 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 1800 | 0.020 |
Why?
|
Photochemistry | 1 | 1991 | 238 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 1992 | 897 | 0.020 |
Why?
|
Chromosome Inversion | 1 | 1991 | 127 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2782 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2000 | 2440 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1994 | 320 | 0.020 |
Why?
|
Propionates | 1 | 1991 | 168 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5702 | 0.020 |
Why?
|
Point Mutation | 1 | 1996 | 1626 | 0.020 |
Why?
|
Reticulocytes | 1 | 1991 | 290 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1991 | 803 | 0.020 |
Why?
|
Cytokines | 1 | 2005 | 7298 | 0.020 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2010 | 37 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2007 | 4791 | 0.020 |
Why?
|
Alprenolol | 1 | 1989 | 8 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 1088 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 1227 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1610 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3615 | 0.020 |
Why?
|
Bucladesine | 1 | 1989 | 121 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 15500 | 0.020 |
Why?
|
Yohimbine | 1 | 1989 | 62 | 0.020 |
Why?
|
Prazosin | 1 | 1989 | 96 | 0.020 |
Why?
|
Protein Binding | 2 | 2008 | 9375 | 0.020 |
Why?
|
Appetite Depressants | 1 | 2010 | 110 | 0.020 |
Why?
|
Retrospective Studies | 7 | 2006 | 76631 | 0.020 |
Why?
|
Isoproterenol | 1 | 1989 | 399 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2000 | 3701 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1884 | 0.020 |
Why?
|
Exons | 1 | 1995 | 2430 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23355 | 0.020 |
Why?
|
Adenoma | 1 | 2000 | 2167 | 0.020 |
Why?
|
Phenylephrine | 1 | 1989 | 302 | 0.020 |
Why?
|
History, 20th Century | 1 | 1997 | 2742 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1993 | 2345 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4983 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3848 | 0.020 |
Why?
|
Prospective Studies | 3 | 2006 | 53037 | 0.020 |
Why?
|
Appetite | 1 | 2010 | 243 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2007 | 5632 | 0.020 |
Why?
|
Median Eminence | 1 | 1987 | 37 | 0.020 |
Why?
|
Hypertension | 1 | 2008 | 8431 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1993 | 2433 | 0.020 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 110 | 0.020 |
Why?
|
Postprandial Period | 1 | 2009 | 293 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1999 | 3671 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1991 | 1402 | 0.020 |
Why?
|
Middle Aged | 9 | 2009 | 212863 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15036 | 0.020 |
Why?
|
Thyroiditis | 1 | 2006 | 84 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2001 | 4026 | 0.020 |
Why?
|
Muscles | 1 | 2011 | 1608 | 0.020 |
Why?
|
Benzofurans | 1 | 1986 | 141 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2008 | 403 | 0.020 |
Why?
|
Time Factors | 5 | 2010 | 40050 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 11699 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2006 | 799 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3802 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2008 | 853 | 0.020 |
Why?
|
Feedback | 1 | 1989 | 788 | 0.020 |
Why?
|
Oocytes | 1 | 1990 | 1185 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1181 | 0.020 |
Why?
|
Amiodarone | 1 | 1986 | 211 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1991 | 1330 | 0.020 |
Why?
|
Risk Factors | 3 | 2007 | 71974 | 0.020 |
Why?
|
RNA Splicing | 1 | 1989 | 904 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14558 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 2007 | 433 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13635 | 0.010 |
Why?
|
Imidazoles | 1 | 1989 | 1207 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2003 | 184 | 0.010 |
Why?
|
Glycoside Hydrolases | 1 | 2003 | 134 | 0.010 |
Why?
|
Feedback, Physiological | 1 | 2006 | 478 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2007 | 750 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3863 | 0.010 |
Why?
|
Fasting | 1 | 2009 | 1587 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3913 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 276 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2000 | 9122 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2007 | 876 | 0.010 |
Why?
|
Child Development | 1 | 1994 | 2213 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1597 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14740 | 0.010 |
Why?
|
Dioxoles | 1 | 2001 | 104 | 0.010 |
Why?
|
Isotope Labeling | 1 | 2003 | 415 | 0.010 |
Why?
|
Digitonin | 1 | 2000 | 27 | 0.010 |
Why?
|
Clathrin | 1 | 2002 | 265 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 473 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6370 | 0.010 |
Why?
|
Plant Proteins | 1 | 2003 | 361 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 2000 | 116 | 0.010 |
Why?
|
Palpation | 1 | 2000 | 166 | 0.010 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2000 | 31 | 0.010 |
Why?
|
Body Temperature | 1 | 2003 | 775 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2009 | 62693 | 0.010 |
Why?
|
Diamide | 1 | 1979 | 17 | 0.010 |
Why?
|
Dinitrophenols | 1 | 1979 | 57 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2003 | 1245 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10945 | 0.010 |
Why?
|
Time | 1 | 2001 | 528 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3585 | 0.010 |
Why?
|
Escherichia coli | 1 | 1992 | 4220 | 0.010 |
Why?
|
Pyrazoles | 1 | 2010 | 1963 | 0.010 |
Why?
|
Aneuploidy | 1 | 2003 | 533 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3689 | 0.010 |
Why?
|
Ligases | 1 | 2000 | 332 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 589 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2001 | 25470 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 918 | 0.010 |
Why?
|
Infant | 1 | 2000 | 34923 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1999 | 829 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 984 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2798 | 0.010 |
Why?
|
United States | 2 | 1997 | 69573 | 0.010 |
Why?
|
Cerebral Cortex | 2 | 2004 | 5721 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2009 | 21694 | 0.010 |
Why?
|
Electroporation | 1 | 1999 | 250 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1989 | 1372 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6452 | 0.010 |
Why?
|
Artifacts | 1 | 2005 | 1905 | 0.010 |
Why?
|
Aged | 5 | 2007 | 162698 | 0.010 |
Why?
|
Cell Polarity | 1 | 1999 | 644 | 0.010 |
Why?
|
Intelligence | 1 | 2001 | 919 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 24714 | 0.010 |
Why?
|
Temperature | 1 | 2001 | 2202 | 0.010 |
Why?
|
Oligopeptides | 1 | 2000 | 1179 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5181 | 0.010 |
Why?
|
NF-kappa B | 1 | 2003 | 2502 | 0.010 |
Why?
|
Massachusetts | 1 | 2008 | 8669 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1986 | 2116 | 0.010 |
Why?
|
Calcinosis | 1 | 2003 | 1493 | 0.010 |
Why?
|
Epitopes | 1 | 2000 | 2558 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2704 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 1999 | 683 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6174 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 35326 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2000 | 1214 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1991 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18349 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12328 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2001 | 2100 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10455 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8400 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15511 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2000 | 1849 | 0.010 |
Why?
|
Acute Disease | 1 | 1982 | 7128 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8613 | 0.010 |
Why?
|
Oxygen | 1 | 2001 | 4158 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6318 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2003 | 3866 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15153 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1989 | 292 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16646 | 0.010 |
Why?
|
Swine | 1 | 1999 | 5901 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1986 | 10142 | 0.010 |
Why?
|
Mitochondria | 1 | 2001 | 3522 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2003 | 10961 | 0.010 |
Why?
|
Peptides | 1 | 2000 | 4395 | 0.010 |
Why?
|
Coronary Disease | 1 | 2003 | 6068 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 17384 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12237 | 0.000 |
Why?
|
Thyroglobulin | 1 | 1986 | 114 | 0.000 |
Why?
|
Smoking | 1 | 2003 | 8960 | 0.000 |
Why?
|
Mass Screening | 1 | 1981 | 5265 | 0.000 |
Why?
|
Postpartum Period | 1 | 1990 | 1070 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 40389 | 0.000 |
Why?
|
Thyroxine-Binding Proteins | 1 | 1982 | 24 | 0.000 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1986 | 1470 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 38942 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 85405 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1989 | 3419 | 0.000 |
Why?
|
Autoantibodies | 1 | 1986 | 2020 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2003 | 15070 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1986 | 5959 | 0.000 |
Why?
|
India | 1 | 1981 | 2189 | 0.000 |
Why?
|
Child | 1 | 2001 | 77033 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1986 | 9259 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1981 | 5462 | 0.000 |
Why?
|